Copyright
©The Author(s) 2017.
World J Gastroenterol. Jun 14, 2017; 23(22): 4039-4046
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.4039
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.4039
Figure 2 Systemic IL-9 in patients with active and inactive Crohn’s disease and ulcerative colitis.
Data presented as geometric means with 95%CI and analyzed using one-way ANOVA. Small letters indicate statistical significance of between-group differences.
- Citation: Matusiewicz M, Neubauer K, Bednarz-Misa I, Gorska S, Krzystek-Korpacka M. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis. World J Gastroenterol 2017; 23(22): 4039-4046
- URL: https://www.wjgnet.com/1007-9327/full/v23/i22/4039.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i22.4039